Updated:
Petauri Health
Petauri Health advises and invests in healthcare enterprises from New York, focusing on pharmaceutical services and value-based care.
Petauri Health
Petauri Health operates as a specialized healthcare advisory and investment platform based in New York. The firm works with pharmaceutical manufacturers and healthcare services companies on market access, medical communications, and value-based strategy. Its dual advisory-and-investment posture places it among a small cohort of firms that deploy capital directly into the therapeutic and service sectors they also consult for. The firm's investment activity concentrates on pharmaceutical services, digital health enablement, and healthcare delivery innovation. It targets companies at the intersection of clinical evidence generation and commercial execution — those helping drug manufacturers prove and communicate product value to payers and providers. Confirmed portfolio companies are not publicly disclosed at the entity level. The geographic focus is primarily North America, with select engagements extending to European biopharma markets. The advisory and investment teams operate from New York, drawing on a network of former pharma executives, health economists, and payer strategists. Team size and total deployment figures are not publicly reported. No adjacent vehicles, philanthropic foundations, or club investor memberships are disclosed. Petauri Health's structural differentiator is its combined advisory and investment architecture: the firm evaluates potential investments through the same market-access and evidence-generation lens it applies to consulting assignments. This creates an information advantage in diligence and portfolio support that pure financial sponsors cannot replicate without in-house clinical and payer expertise.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, United States
Sector focus
Frequently asked questions
What does Petauri Health invest in?
Petauri Health invests in healthcare services and digital health companies that support pharmaceutical manufacturers with market access, evidence generation, and commercialization. The firm does not publicly disclose a full list of portfolio companies or an explicit stage mandate. Its investment activity overlaps with its advisory practice, which focuses on payer engagement and health economic strategy for drug launches and lifecycle management.
Who runs Petauri Health?
Petauri Health's leadership is composed of healthcare industry executives with experience across pharmaceutical companies, consulting firms, and payer organizations. Specific named principals have not been publicly disclosed at the entity level, and the firm does not prominently feature individual leadership profiles on its public-facing materials.
How does Petauri Health structure its advisory and investment work?
The firm operates a hybrid model where an advisory business serving pharmaceutical and healthcare-services clients runs alongside a capital allocation function. Advisory engagements often inform how the firm evaluates potential investment opportunities, particularly around market access risk, reimbursement pathways, and commercial viability. The firm does not publicly separate investment and advisory headcount or balance sheet.
Does Petauri Health manage outside capital or proprietary capital?
Public information does not clarify whether Petauri Health deploys proprietary balance-sheet capital, third-party managed funds, or a combination. The firm has not disclosed an AUM figure, fund structure, or limited-partner composition.
Which healthcare sub-sectors does Petauri Health avoid?
The firm does not publish exclusion criteria, but its public focus on commercialization advisory suggests limited activity in early-stage drug discovery, preclinical biotechnology, or pure medical-device hardware where market-access strategy is less central to value creation. Its positioning implies a preference for post-approval, commercial-stage healthcare services and enablement.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: